Global IVIG Market Growth 2025-2031

Product Code: 1676071

Industry: Pharma & Healthcare

Published: Jun 25,2025

Pages: 128

Delivery Time: 2-3 business days

Global IVIG Market Growth 2025-2031

Product Code: 1676071

Industry: Pharma & Healthcare

Published: Jun 25,2025

Pages: 128

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global IVIG market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for IVIG is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for IVIG is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for IVIG is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key IVIG players cover Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “IVIG Industry Forecast” looks at past sales and reviews total world IVIG sales in 2024, providing a comprehensive analysis by region and market sector of projected IVIG sales for 2025 through 2031. With IVIG sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVIG industry.

This Insight Report provides a comprehensive analysis of the global IVIG landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVIG portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVIG market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVIG and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVIG.

This report presents a comprehensive overview, market shares, and growth opportunities of IVIG market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Injection IVIG
    Lyophilized Powder IVIG

Segmentation by Application:
    Multiple Sclerosis(MS)
    Myasthenia Gravis(MG)
    Multifocal Motor Neuropathy(MMN)
    Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
    Dermatomyositis
    Polymyositis

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Green Cross
    BSV
    Hualan Bio
    RAAS
    YUAN DA SHUYANG
    Kangbao Bio
    Tiantan Bio
    Taibang Bio
    Weiguang Bio
    SIBP
    TONROL
    RUIDE Bio
    BOYA Bio
    RUIDE Bio
    Xinxing Medicine
    Weilun Bio
    WIBP

Key Questions Addressed in this Report
What is the 10-year outlook for the global IVIG market?
What factors are driving IVIG market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IVIG market opportunities vary by end market size?
How does IVIG break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global IVIG Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for IVIG by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for IVIG by Country/Region, 2020, 2024 & 2031
    2.2 IVIG Segment by Type
        2.2.1 Injection IVIG
        2.2.2 Lyophilized Powder IVIG
    2.3 IVIG Sales by Type
        2.3.1 Global IVIG Sales Market Share by Type (2020-2025)
        2.3.2 Global IVIG Revenue and Market Share by Type (2020-2025)
        2.3.3 Global IVIG Sale Price by Type (2020-2025)
    2.4 IVIG Segment by Application
        2.4.1 Multiple Sclerosis(MS)
        2.4.2 Myasthenia Gravis(MG)
        2.4.3 Multifocal Motor Neuropathy(MMN)
        2.4.4 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
        2.4.5 Dermatomyositis
        2.4.6 Polymyositis
    2.5 IVIG Sales by Application
        2.5.1 Global IVIG Sale Market Share by Application (2020-2025)
        2.5.2 Global IVIG Revenue and Market Share by Application (2020-2025)
        2.5.3 Global IVIG Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global IVIG Breakdown Data by Company
        3.1.1 Global IVIG Annual Sales by Company (2020-2025)
        3.1.2 Global IVIG Sales Market Share by Company (2020-2025)
    3.2 Global IVIG Annual Revenue by Company (2020-2025)
        3.2.1 Global IVIG Revenue by Company (2020-2025)
        3.2.2 Global IVIG Revenue Market Share by Company (2020-2025)
    3.3 Global IVIG Sale Price by Company
    3.4 Key Manufacturers IVIG Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers IVIG Product Location Distribution
        3.4.2 Players IVIG Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for IVIG by Geographic Region
    4.1 World Historic IVIG Market Size by Geographic Region (2020-2025)
        4.1.1 Global IVIG Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global IVIG Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic IVIG Market Size by Country/Region (2020-2025)
        4.2.1 Global IVIG Annual Sales by Country/Region (2020-2025)
        4.2.2 Global IVIG Annual Revenue by Country/Region (2020-2025)
    4.3 Americas IVIG Sales Growth
    4.4 APAC IVIG Sales Growth
    4.5 Europe IVIG Sales Growth
    4.6 Middle East & Africa IVIG Sales Growth

5 Americas
    5.1 Americas IVIG Sales by Country
        5.1.1 Americas IVIG Sales by Country (2020-2025)
        5.1.2 Americas IVIG Revenue by Country (2020-2025)
    5.2 Americas IVIG Sales by Type (2020-2025)
    5.3 Americas IVIG Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC IVIG Sales by Region
        6.1.1 APAC IVIG Sales by Region (2020-2025)
        6.1.2 APAC IVIG Revenue by Region (2020-2025)
    6.2 APAC IVIG Sales by Type (2020-2025)
    6.3 APAC IVIG Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe IVIG by Country
        7.1.1 Europe IVIG Sales by Country (2020-2025)
        7.1.2 Europe IVIG Revenue by Country (2020-2025)
    7.2 Europe IVIG Sales by Type (2020-2025)
    7.3 Europe IVIG Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa IVIG by Country
        8.1.1 Middle East & Africa IVIG Sales by Country (2020-2025)
        8.1.2 Middle East & Africa IVIG Revenue by Country (2020-2025)
    8.2 Middle East & Africa IVIG Sales by Type (2020-2025)
    8.3 Middle East & Africa IVIG Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of IVIG
    10.3 Manufacturing Process Analysis of IVIG
    10.4 Industry Chain Structure of IVIG

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 IVIG Distributors
    11.3 IVIG Customer

12 World Forecast Review for IVIG by Geographic Region
    12.1 Global IVIG Market Size Forecast by Region
        12.1.1 Global IVIG Forecast by Region (2026-2031)
        12.1.2 Global IVIG Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global IVIG Forecast by Type (2026-2031)
    12.7 Global IVIG Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Green Cross
        13.1.1 Green Cross Company Information
        13.1.2 Green Cross IVIG Product Portfolios and Specifications
        13.1.3 Green Cross IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Green Cross Main Business Overview
        13.1.5 Green Cross Latest Developments
    13.2 BSV
        13.2.1 BSV Company Information
        13.2.2 BSV IVIG Product Portfolios and Specifications
        13.2.3 BSV IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 BSV Main Business Overview
        13.2.5 BSV Latest Developments
    13.3 Hualan Bio
        13.3.1 Hualan Bio Company Information
        13.3.2 Hualan Bio IVIG Product Portfolios and Specifications
        13.3.3 Hualan Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Hualan Bio Main Business Overview
        13.3.5 Hualan Bio Latest Developments
    13.4 RAAS
        13.4.1 RAAS Company Information
        13.4.2 RAAS IVIG Product Portfolios and Specifications
        13.4.3 RAAS IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 RAAS Main Business Overview
        13.4.5 RAAS Latest Developments
    13.5 YUAN DA SHUYANG
        13.5.1 YUAN DA SHUYANG Company Information
        13.5.2 YUAN DA SHUYANG IVIG Product Portfolios and Specifications
        13.5.3 YUAN DA SHUYANG IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 YUAN DA SHUYANG Main Business Overview
        13.5.5 YUAN DA SHUYANG Latest Developments
    13.6 Kangbao Bio
        13.6.1 Kangbao Bio Company Information
        13.6.2 Kangbao Bio IVIG Product Portfolios and Specifications
        13.6.3 Kangbao Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Kangbao Bio Main Business Overview
        13.6.5 Kangbao Bio Latest Developments
    13.7 Tiantan Bio
        13.7.1 Tiantan Bio Company Information
        13.7.2 Tiantan Bio IVIG Product Portfolios and Specifications
        13.7.3 Tiantan Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Tiantan Bio Main Business Overview
        13.7.5 Tiantan Bio Latest Developments
    13.8 Taibang Bio
        13.8.1 Taibang Bio Company Information
        13.8.2 Taibang Bio IVIG Product Portfolios and Specifications
        13.8.3 Taibang Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Taibang Bio Main Business Overview
        13.8.5 Taibang Bio Latest Developments
    13.9 Weiguang Bio
        13.9.1 Weiguang Bio Company Information
        13.9.2 Weiguang Bio IVIG Product Portfolios and Specifications
        13.9.3 Weiguang Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 Weiguang Bio Main Business Overview
        13.9.5 Weiguang Bio Latest Developments
    13.10 SIBP
        13.10.1 SIBP Company Information
        13.10.2 SIBP IVIG Product Portfolios and Specifications
        13.10.3 SIBP IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 SIBP Main Business Overview
        13.10.5 SIBP Latest Developments
    13.11 TONROL
        13.11.1 TONROL Company Information
        13.11.2 TONROL IVIG Product Portfolios and Specifications
        13.11.3 TONROL IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 TONROL Main Business Overview
        13.11.5 TONROL Latest Developments
    13.12 RUIDE Bio
        13.12.1 RUIDE Bio Company Information
        13.12.2 RUIDE Bio IVIG Product Portfolios and Specifications
        13.12.3 RUIDE Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 RUIDE Bio Main Business Overview
        13.12.5 RUIDE Bio Latest Developments
    13.13 BOYA Bio
        13.13.1 BOYA Bio Company Information
        13.13.2 BOYA Bio IVIG Product Portfolios and Specifications
        13.13.3 BOYA Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.13.4 BOYA Bio Main Business Overview
        13.13.5 BOYA Bio Latest Developments
    13.14 RUIDE Bio
        13.14.1 RUIDE Bio Company Information
        13.14.2 RUIDE Bio IVIG Product Portfolios and Specifications
        13.14.3 RUIDE Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.14.4 RUIDE Bio Main Business Overview
        13.14.5 RUIDE Bio Latest Developments
    13.15 Xinxing Medicine
        13.15.1 Xinxing Medicine Company Information
        13.15.2 Xinxing Medicine IVIG Product Portfolios and Specifications
        13.15.3 Xinxing Medicine IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.15.4 Xinxing Medicine Main Business Overview
        13.15.5 Xinxing Medicine Latest Developments
    13.16 Weilun Bio
        13.16.1 Weilun Bio Company Information
        13.16.2 Weilun Bio IVIG Product Portfolios and Specifications
        13.16.3 Weilun Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.16.4 Weilun Bio Main Business Overview
        13.16.5 Weilun Bio Latest Developments
    13.17 WIBP
        13.17.1 WIBP Company Information
        13.17.2 WIBP IVIG Product Portfolios and Specifications
        13.17.3 WIBP IVIG Sales, Revenue, Price and Gross Margin (2020-2025)
        13.17.4 WIBP Main Business Overview
        13.17.5 WIBP Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. IVIG Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. IVIG Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Injection IVIG
 Table 4. Major Players of Lyophilized Powder IVIG
 Table 5. Global IVIG Sales by Type (2020-2025) & (K Pcs)
 Table 6. Global IVIG Sales Market Share by Type (2020-2025)
 Table 7. Global IVIG Revenue by Type (2020-2025) & ($ million)
 Table 8. Global IVIG Revenue Market Share by Type (2020-2025)
 Table 9. Global IVIG Sale Price by Type (2020-2025) & (USD/Pcs)
 Table 10. Global IVIG Sale by Application (2020-2025) & (K Pcs)
 Table 11. Global IVIG Sale Market Share by Application (2020-2025)
 Table 12. Global IVIG Revenue by Application (2020-2025) & ($ million)
 Table 13. Global IVIG Revenue Market Share by Application (2020-2025)
 Table 14. Global IVIG Sale Price by Application (2020-2025) & (USD/Pcs)
 Table 15. Global IVIG Sales by Company (2020-2025) & (K Pcs)
 Table 16. Global IVIG Sales Market Share by Company (2020-2025)
 Table 17. Global IVIG Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global IVIG Revenue Market Share by Company (2020-2025)
 Table 19. Global IVIG Sale Price by Company (2020-2025) & (USD/Pcs)
 Table 20. Key Manufacturers IVIG Producing Area Distribution and Sales Area
 Table 21. Players IVIG Products Offered
 Table 22. IVIG Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global IVIG Sales by Geographic Region (2020-2025) & (K Pcs)
 Table 26. Global IVIG Sales Market Share Geographic Region (2020-2025)
 Table 27. Global IVIG Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global IVIG Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global IVIG Sales by Country/Region (2020-2025) & (K Pcs)
 Table 30. Global IVIG Sales Market Share by Country/Region (2020-2025)
 Table 31. Global IVIG Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global IVIG Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas IVIG Sales by Country (2020-2025) & (K Pcs)
 Table 34. Americas IVIG Sales Market Share by Country (2020-2025)
 Table 35. Americas IVIG Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas IVIG Sales by Type (2020-2025) & (K Pcs)
 Table 37. Americas IVIG Sales by Application (2020-2025) & (K Pcs)
 Table 38. APAC IVIG Sales by Region (2020-2025) & (K Pcs)
 Table 39. APAC IVIG Sales Market Share by Region (2020-2025)
 Table 40. APAC IVIG Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC IVIG Sales by Type (2020-2025) & (K Pcs)
 Table 42. APAC IVIG Sales by Application (2020-2025) & (K Pcs)
 Table 43. Europe IVIG Sales by Country (2020-2025) & (K Pcs)
 Table 44. Europe IVIG Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe IVIG Sales by Type (2020-2025) & (K Pcs)
 Table 46. Europe IVIG Sales by Application (2020-2025) & (K Pcs)
 Table 47. Middle East & Africa IVIG Sales by Country (2020-2025) & (K Pcs)
 Table 48. Middle East & Africa IVIG Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa IVIG Sales by Type (2020-2025) & (K Pcs)
 Table 50. Middle East & Africa IVIG Sales by Application (2020-2025) & (K Pcs)
 Table 51. Key Market Drivers & Growth Opportunities of IVIG
 Table 52. Key Market Challenges & Risks of IVIG
 Table 53. Key Industry Trends of IVIG
 Table 54. IVIG Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. IVIG Distributors List
 Table 57. IVIG Customer List
 Table 58. Global IVIG Sales Forecast by Region (2026-2031) & (K Pcs)
 Table 59. Global IVIG Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas IVIG Sales Forecast by Country (2026-2031) & (K Pcs)
 Table 61. Americas IVIG Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC IVIG Sales Forecast by Region (2026-2031) & (K Pcs)
 Table 63. APAC IVIG Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe IVIG Sales Forecast by Country (2026-2031) & (K Pcs)
 Table 65. Europe IVIG Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa IVIG Sales Forecast by Country (2026-2031) & (K Pcs)
 Table 67. Middle East & Africa IVIG Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global IVIG Sales Forecast by Type (2026-2031) & (K Pcs)
 Table 69. Global IVIG Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global IVIG Sales Forecast by Application (2026-2031) & (K Pcs)
 Table 71. Global IVIG Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Green Cross Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 73. Green Cross IVIG Product Portfolios and Specifications
 Table 74. Green Cross IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 75. Green Cross Main Business
 Table 76. Green Cross Latest Developments
 Table 77. BSV Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 78. BSV IVIG Product Portfolios and Specifications
 Table 79. BSV IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 80. BSV Main Business
 Table 81. BSV Latest Developments
 Table 82. Hualan Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 83. Hualan Bio IVIG Product Portfolios and Specifications
 Table 84. Hualan Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 85. Hualan Bio Main Business
 Table 86. Hualan Bio Latest Developments
 Table 87. RAAS Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 88. RAAS IVIG Product Portfolios and Specifications
 Table 89. RAAS IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 90. RAAS Main Business
 Table 91. RAAS Latest Developments
 Table 92. YUAN DA SHUYANG Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 93. YUAN DA SHUYANG IVIG Product Portfolios and Specifications
 Table 94. YUAN DA SHUYANG IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 95. YUAN DA SHUYANG Main Business
 Table 96. YUAN DA SHUYANG Latest Developments
 Table 97. Kangbao Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 98. Kangbao Bio IVIG Product Portfolios and Specifications
 Table 99. Kangbao Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 100. Kangbao Bio Main Business
 Table 101. Kangbao Bio Latest Developments
 Table 102. Tiantan Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 103. Tiantan Bio IVIG Product Portfolios and Specifications
 Table 104. Tiantan Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 105. Tiantan Bio Main Business
 Table 106. Tiantan Bio Latest Developments
 Table 107. Taibang Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 108. Taibang Bio IVIG Product Portfolios and Specifications
 Table 109. Taibang Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 110. Taibang Bio Main Business
 Table 111. Taibang Bio Latest Developments
 Table 112. Weiguang Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 113. Weiguang Bio IVIG Product Portfolios and Specifications
 Table 114. Weiguang Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 115. Weiguang Bio Main Business
 Table 116. Weiguang Bio Latest Developments
 Table 117. SIBP Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 118. SIBP IVIG Product Portfolios and Specifications
 Table 119. SIBP IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 120. SIBP Main Business
 Table 121. SIBP Latest Developments
 Table 122. TONROL Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 123. TONROL IVIG Product Portfolios and Specifications
 Table 124. TONROL IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 125. TONROL Main Business
 Table 126. TONROL Latest Developments
 Table 127. RUIDE Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 128. RUIDE Bio IVIG Product Portfolios and Specifications
 Table 129. RUIDE Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 130. RUIDE Bio Main Business
 Table 131. RUIDE Bio Latest Developments
 Table 132. BOYA Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 133. BOYA Bio IVIG Product Portfolios and Specifications
 Table 134. BOYA Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 135. BOYA Bio Main Business
 Table 136. BOYA Bio Latest Developments
 Table 137. RUIDE Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 138. RUIDE Bio IVIG Product Portfolios and Specifications
 Table 139. RUIDE Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 140. RUIDE Bio Main Business
 Table 141. RUIDE Bio Latest Developments
 Table 142. Xinxing Medicine Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 143. Xinxing Medicine IVIG Product Portfolios and Specifications
 Table 144. Xinxing Medicine IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 145. Xinxing Medicine Main Business
 Table 146. Xinxing Medicine Latest Developments
 Table 147. Weilun Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 148. Weilun Bio IVIG Product Portfolios and Specifications
 Table 149. Weilun Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 150. Weilun Bio Main Business
 Table 151. Weilun Bio Latest Developments
 Table 152. WIBP Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
 Table 153. WIBP IVIG Product Portfolios and Specifications
 Table 154. WIBP IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 155. WIBP Main Business
 Table 156. WIBP Latest Developments


List of Figures
 Figure 1. Picture of IVIG
 Figure 2. IVIG Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global IVIG Sales Growth Rate 2020-2031 (K Pcs)
 Figure 7. Global IVIG Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. IVIG Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. IVIG Sales Market Share by Country/Region (2024)
 Figure 10. IVIG Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Injection IVIG
 Figure 12. Product Picture of Lyophilized Powder IVIG
 Figure 13. Global IVIG Sales Market Share by Type in 2025
 Figure 14. Global IVIG Revenue Market Share by Type (2020-2025)
 Figure 15. IVIG Consumed in Multiple Sclerosis(MS)
 Figure 16. Global IVIG Market: Multiple Sclerosis(MS) (2020-2025) & (K Pcs)
 Figure 17. IVIG Consumed in Myasthenia Gravis(MG)
 Figure 18. Global IVIG Market: Myasthenia Gravis(MG) (2020-2025) & (K Pcs)
 Figure 19. IVIG Consumed in Multifocal Motor Neuropathy(MMN)
 Figure 20. Global IVIG Market: Multifocal Motor Neuropathy(MMN) (2020-2025) & (K Pcs)
 Figure 21. IVIG Consumed in Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
 Figure 22. Global IVIG Market: Multifocal Acquired Sensory and Motor Neuropathy(MADSAM) (2020-2025) & (K Pcs)
 Figure 23. IVIG Consumed in Dermatomyositis
 Figure 24. Global IVIG Market: Dermatomyositis (2020-2025) & (K Pcs)
 Figure 25. IVIG Consumed in Polymyositis
 Figure 26. Global IVIG Market: Polymyositis (2020-2025) & (K Pcs)
 Figure 27. Global IVIG Sale Market Share by Application (2024)
 Figure 28. Global IVIG Revenue Market Share by Application in 2025
 Figure 29. IVIG Sales by Company in 2025 (K Pcs)
 Figure 30. Global IVIG Sales Market Share by Company in 2025
 Figure 31. IVIG Revenue by Company in 2025 ($ millions)
 Figure 32. Global IVIG Revenue Market Share by Company in 2025
 Figure 33. Global IVIG Sales Market Share by Geographic Region (2020-2025)
 Figure 34. Global IVIG Revenue Market Share by Geographic Region in 2025
 Figure 35. Americas IVIG Sales 2020-2025 (K Pcs)
 Figure 36. Americas IVIG Revenue 2020-2025 ($ millions)
 Figure 37. APAC IVIG Sales 2020-2025 (K Pcs)
 Figure 38. APAC IVIG Revenue 2020-2025 ($ millions)
 Figure 39. Europe IVIG Sales 2020-2025 (K Pcs)
 Figure 40. Europe IVIG Revenue 2020-2025 ($ millions)
 Figure 41. Middle East & Africa IVIG Sales 2020-2025 (K Pcs)
 Figure 42. Middle East & Africa IVIG Revenue 2020-2025 ($ millions)
 Figure 43. Americas IVIG Sales Market Share by Country in 2025
 Figure 44. Americas IVIG Revenue Market Share by Country (2020-2025)
 Figure 45. Americas IVIG Sales Market Share by Type (2020-2025)
 Figure 46. Americas IVIG Sales Market Share by Application (2020-2025)
 Figure 47. United States IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 48. Canada IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 49. Mexico IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 50. Brazil IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 51. APAC IVIG Sales Market Share by Region in 2025
 Figure 52. APAC IVIG Revenue Market Share by Region (2020-2025)
 Figure 53. APAC IVIG Sales Market Share by Type (2020-2025)
 Figure 54. APAC IVIG Sales Market Share by Application (2020-2025)
 Figure 55. China IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 56. Japan IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 57. South Korea IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 58. Southeast Asia IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 59. India IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 60. Australia IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 61. China Taiwan IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 62. Europe IVIG Sales Market Share by Country in 2025
 Figure 63. Europe IVIG Revenue Market Share by Country (2020-2025)
 Figure 64. Europe IVIG Sales Market Share by Type (2020-2025)
 Figure 65. Europe IVIG Sales Market Share by Application (2020-2025)
 Figure 66. Germany IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 67. France IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 68. UK IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 69. Italy IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 70. Russia IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 71. Middle East & Africa IVIG Sales Market Share by Country (2020-2025)
 Figure 72. Middle East & Africa IVIG Sales Market Share by Type (2020-2025)
 Figure 73. Middle East & Africa IVIG Sales Market Share by Application (2020-2025)
 Figure 74. Egypt IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 75. South Africa IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 76. Israel IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 77. Turkey IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 78. GCC Countries IVIG Revenue Growth 2020-2025 ($ millions)
 Figure 79. Manufacturing Cost Structure Analysis of IVIG in 2025
 Figure 80. Manufacturing Process Analysis of IVIG
 Figure 81. Industry Chain Structure of IVIG
 Figure 82. Channels of Distribution
 Figure 83. Global IVIG Sales Market Forecast by Region (2026-2031)
 Figure 84. Global IVIG Revenue Market Share Forecast by Region (2026-2031)
 Figure 85. Global IVIG Sales Market Share Forecast by Type (2026-2031)
 Figure 86. Global IVIG Revenue Market Share Forecast by Type (2026-2031)
 Figure 87. Global IVIG Sales Market Share Forecast by Application (2026-2031)
 Figure 88. Global IVIG Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Green Cross

BSV

Hualan Bio

RAAS

YUAN DA SHUYANG

Kangbao Bio

Tiantan Bio

Taibang Bio

Weiguang Bio

SIBP

TONROL

RUIDE Bio

BOYA Bio

RUIDE Bio

Xinxing Medicine

Weilun Bio

WIBP

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff